Testing a new drug for bone metastases from solid tumors
Part of Bones, joints & muscles, Cancer clinical trials.
This trial tests a new drug called SHR-2017 for people with solid tumors that have spread to the bones. The study aims to see if the drug can help manage pain and other effects of bone metastases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid tumor that was confirmed by a biopsy or other lab test.
- You have at least one area where the cancer has spread to a bone (this must be seen on a scan or confirmed by tissue biopsy).
- You are able to take care of yourself (doctor's rating of 0 or 1 or 2 on a standard scale).
- You have not received radiation or certain other treatments for your bones just before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.
This trial tests a new drug, BPR-6023021, for people whose cancer has spread to the bones and who have run out of standard options. The goal is to see if it can help control the cancer and ease symptoms.
This study tests a new drug called SHR-4298 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug, SHR-1826, combined with other cancer treatments for people with advanced solid tumors that have not responded to prior therapy. The goal is to see if the combination is safe and effective.
This trial tests a new drug called SHR-3276 for people with advanced cancers that haven't responded to standard treatments. It aims to see if the drug is safe and works against tumors.
This trial tests a new drug, SHR-2022, for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and effective.
Hear when a new For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.